Will cefdinir be effective for treating both conjunctivitis (pink eye) and an ear infection (acute otitis media)?

Cefdinir for Pink Eye and Ear Infection

Cefdinir will effectively cover an ear infection (acute otitis media) but is NOT appropriate for treating pink eye (conjunctivitis), as bacterial conjunctivitis requires topical ophthalmic antibiotics, not oral therapy.

Coverage for Ear Infection (Acute Otitis Media)

Cefdinir is FDA-approved and guideline-supported for treating acute otitis media in pediatric patients 1. The drug provides coverage against the three most common bacterial pathogens causing ear infections:

• Haemophilus influenzae (including β-lactamase producing strains)
• Streptococcus pneumoniae (penicillin-susceptible strains)
• Moraxella catarrhalis (including β-lactamase producing strains)

Clinical efficacy data supports cefdinir for AOM, with cure rates of 73-86% demonstrated in multiple studies 2, 3, 4. The 2013 AAP guidelines specifically list cefdinir as an acceptable alternative for patients who have received amoxicillin in the previous 30 days or for those with penicillin allergy 5.

Dosing for AOM

• 7 mg/kg twice daily for 5-10 days
• 14 mg/kg once daily is also effective 1, 3

Important Caveat

One high-quality 2012 study found that 5-day cefdinir was significantly less effective than 10-day high-dose amoxicillin-clavulanate (71% vs 86.5% cure rate, p=0.001), with effectiveness decreasing as children aged from 6-24 months 6. This suggests cefdinir may be suboptimal as first-line therapy, particularly in older infants and toddlers.

No Coverage for Pink Eye (Conjunctivitis)

Cefdinir is NOT indicated for treating conjunctivitis 1. The 2024 Conjunctivitis Preferred Practice Pattern guidelines make clear that:

• Bacterial conjunctivitis requires topical ophthalmic antibiotics, not systemic oral therapy 7
• Mild bacterial conjunctivitis is often self-limited and resolves without treatment
• When treatment is indicated, a 5-7 day course of topical broad-spectrum antibiotics (such as erythromycin ointment or fluoroquinolone drops) is recommended 7

Critical Exception: Otitis-Conjunctivitis Syndrome

There is ONE scenario where systemic antibiotics may be considered for conjunctivitis: otitis-conjunctivitis syndrome, where purulent conjunctivitis occurs simultaneously with AOM. The 2013 AAP guidelines note that amoxicillin-clavulanate (not cefdinir) may be preferred in this specific situation 5. Recent data shows that patients with concurrent conjunctivitis and AOM are significantly more likely to receive intramuscular ceftriaxone (14.5% vs 5.0%, p<0.0001) 8, suggesting clinicians recognize this as a more resistant pattern requiring broader coverage.

Clinical Algorithm

For isolated pink eye:

• Use topical ophthalmic antibiotics (erythromycin ointment or fluoroquinolone drops)
• Do NOT use oral cefdinir

For isolated ear infection:

• Cefdinir is acceptable as second-line therapy
• First-line remains high-dose amoxicillin (80-90 mg/kg/day)
• Consider 10-day duration rather than 5-day for better efficacy

For pink eye + ear infection together (otitis-conjunctivitis syndrome):

• Consider high-dose amoxicillin-clavulanate as preferred agent 5
• Add topical ophthalmic antibiotics for the conjunctivitis
• Cefdinir alone would be inadequate for the conjunctivitis component